GENOME EDITINGFOR A BETTER LIFE

> Gene Editing> Manufacturing

GMP Manufacturing Base

  • Guangzhou Base


    - 1600 m² GMP manufacturing base with clinical-scale manufacturing capacity


  • Complete, Efficient and Stable Manufacturing Capacity and Quality Control

    - An enlarged and stable manufacturing process in order to keep important parameters stable in the whole process


    - The gene editing efficiency with guaranteed efficacy and safety


  • Poster Presentation at the 61st ASH Annual Meeting

    In December 2019, at the 61st ASH Annual Meeting, presented preclinical data on ET-01, its leading therapeutic program for patients with β-Thalassemia Major, during the 61st American Society of Hematology (ASH) Annual Meeting. 


    The presentation highlighted selected data from scaled-up manufacturing campaigns at clinical scale and IND-enabling preclinical studies of ET-01.